Alpha-Thalassemia Trait (Silent Carrier or α-Thalassemia Minor)
This patient most likely has alpha-thalassemia trait, given the combination of microcytic hypochromic anemia with target cells, normal ferritin (250 ng/mL), and critically, normal hemoglobin electrophoresis.
Diagnostic Reasoning
The key to this diagnosis lies in systematically excluding other causes of microcytic anemia with elevated or normal ferritin:
Why Alpha-Thalassemia is Most Likely:
- Normal hemoglobin electrophoresis excludes beta-thalassemia trait (which would show elevated HbA2 >3.5%) 1
- Normal ferritin (250 ng/mL) excludes iron deficiency anemia 1
- Target cells on peripheral smear are characteristic of thalassemia syndromes 2, 3
- Microcytosis (MCV 76) with hypochromia (MCH 25) fits the thalassemia pattern 3
- Normal RDW (15%) - while slightly elevated, this is less pronounced than typically seen in iron deficiency 3
Critical Distinguishing Feature:
Alpha-thalassemia trait characteristically shows NORMAL hemoglobin electrophoresis because the defect involves alpha-globin chains, which are present in HbA, HbA2, and HbF equally. Standard electrophoresis cannot detect the proportional reduction 4, 5.
Genetic Disorders Excluded by This Presentation:
According to the 2014 Blood guidelines on genetic microcytic anemias 6:
- Sideroblastic anemias (SLC25A38, ALAS2, ABCB7, STEAP3 defects) would show ring sideroblasts on bone marrow examination and typically present with more severe anemia or additional features 6
- Iron metabolism defects (TMPRSS6, TF, SLC11A2) would show abnormal iron parameters - either very low or very high transferrin saturation 6
- Beta-thalassemia trait is excluded by normal HbA2 on electrophoresis 1
Diagnostic Confirmation
To confirm alpha-thalassemia trait, molecular genetic testing is required:
- Multiplex PCR for common alpha-globin gene deletions (most common: -α3.7 and -α4.2 deletions)
- Sequencing of HBA1 and HBA2 genes if deletions are not found
- MLPA (multiplex ligation-dependent probe amplification) for copy number variants 5
Important caveat: Even comprehensive molecular testing may not identify all cases, as some rare variants or regulatory mutations may be missed by standard panels 5. The clinical phenotype (stable microcytosis with normal ferritin and normal electrophoresis) remains the strongest diagnostic indicator.
Clinical Implications
- No treatment is required - alpha-thalassemia trait is a benign condition 4
- Genetic counseling is essential - if both parents carry alpha-thalassemia trait, offspring risk HbH disease (3-gene deletion) or hydrops fetalis (4-gene deletion) 4
- Avoid unnecessary iron supplementation - this patient has adequate iron stores (ferritin 250) and iron therapy will not improve the anemia 1, 4
- Family screening should be offered, particularly if the patient is of reproductive age 6
Common Pitfall to Avoid
The most critical error would be treating this as iron deficiency anemia based solely on microcytosis. The normal ferritin definitively excludes iron deficiency 1. Inappropriate iron supplementation in thalassemia trait can lead to iron overload over time, though this is more concerning in transfusion-dependent thalassemias 6.